S. Nakae et al., ANALYSIS OF PROLIFERATIVE ACTIVITY USING ANTIPROLIFERATING CELL NUCLEAR ANTIGEN-ANTIBODY IN COLORECTAL-CANCER, Journal of surgical oncology, 60(3), 1995, pp. 149-153
Using anti-PCNA antibody (PC10), an immunohistochemical study of the e
xpression of PCNA in formalin-fixed and paraffin-embedded materials of
colorectal cancer patients was performed and correlation of PCNA expr
ession with clinicopathological findings and DNA ploidy pattern was st
udied. PCNA labeling rate (PCNA LR) was estimated in the advancing mar
gin of the tumor and ranged from 23.8% to 77.9%. There was a significa
nt difference in lymphatic vessel invasion, liver metastasis and Dukes
' stage between the groups with high (> 48.7) and low (< 48.7) PCNA LR
(P < 0.05). No differences were seen in tumor size, histological type
, lymphnode metastasis or DNA ploidy pattern. In patients with younger
age, infiltration to neighboring organs, a high degree of venous inva
sion, and peritoneal dissemination, the frequency of high PCNA LR tend
ed to be higher (P < 0.1). The results above suggest that a high proli
ferative activity as defined by evaluation of the PCNA LR at the advan
cing margin of the tumor may be one of the parameters of malignant pot
ential and helpful as a predictor of liver metastasis in colorectal ca
ncer. (C) 1995 Wiley-Liss, Inc.